Aadi Bioscience
Quarterly Financials
| Values in thousands | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|
| Revenue | $5,353 | $6,326 | $5,959 | $6,202 |
| Gross Profit | 4,701 | 5,399 | 5,262 | 5,546 |
| EBITDA | -19,462 | -17,670 | -17,849 | -17,910 |
| EBIT | -19,512 | -17,714 | -17,893 | -17,953 |
| Net Income | -18,289 | -16,268 | -16,302 | -17,971 |
| Net Change In Cash | 5,353 | 6,326 | 5,959 | 6,202 |
| Cost of Revenue | 34,116 | |||
| Free Cash Flow | -20,392 | -10,460 | -13,049 | -17,447 |
| Cash | 53,780 | 62,888 | 68,803 | 68,162 |
| Basic Shares | 26,980 | 26,965 | 26,946 | 26,879 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
| Revenue | $24,354 | $15,216 | $1,000 | $14,000 |
| Gross Profit | 21,545 | 13,881 | 724 | 13,824 |
| EBITDA | -71,764 | -56,559 | -35,463 | -2,652 |
| EBIT | -71,933 | -58,957 | -111,217 | -2,549 |
| Net Income | -65,765 | -57,010 | -110,090 | -3,478 |
| Net Change In Cash | 24,354 | 15,216 | 1,000 | 14,000 |
| Cost of Revenue | 144,534 | 4,080 | ||
| Free Cash Flow | -63,635 | -50,084 | -22,469 | -12,701 |
| Cash | 62,888 | 39,019 | 148,989 | 4,455 |
| Basic Shares | 26,917 | 22,511 | 8,923 | 2,542 |
Earnings Calls
| Quarter | EPS |
|---|---|
| 2024-03-31 | -$0.68 |
| 2023-12-31 | -$0.60 |
| 2023-09-30 | -$0.60 |
| 2023-06-30 | -$0.67 |
